BUZZ - Iambic Therapeutics, backed by Nvidia, sees its stock price fall below the IPO issue price
路透社2026/10/19 14:56October 19 - ** Shares of drug development company Iambic Therapeutics (IAM.O), backed by artificial intelligence giant Nvidia (NVDA.O), plunged as much as 41% to $14.10 on Monday in their third trading day
** IAM opened at $16.15 on Thursday after the company (link) completed its $150 million initial public offering (IPO) at a price of $16 per share, which was at the midpoint of its price range (link)
** The shares closed up about 26% on Friday at $23.81, after hitting an intraday high of $25
** Despite market volatility and a surge in bond yields dampening investor appetite for new issues (link), biotech IPOs (link) are still continuing
** Iambic is advancing its pipeline of experimental drugs for treating solid tumors, developed using its artificial intelligence platform. The company has established partnerships with leading pharmaceutical companies including AbbVie (ABBV.N) and Takeda Pharmaceutical (4502.T)
(To assist non-English speakers, Reuters offers automated translations of its reports in several other languages. Due to possible errors or the lack of necessary context in automated translations, Reuters does not guarantee the accuracy of automated translated texts, which are provided solely for reader convenience. Reuters accepts no responsibility for any damage or loss caused by the use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Korean retail investors start bottom fishing! Their targets are still "Samsung and SK Hynix leveraged ETFs"
Amid a sharp drop in Korean stocks, Korean retail investors turned contrarian, making a net purchase of over 315.4 billion KRW in leveraged products of Samsung and SK Hynix in October alone. They simultaneously spent 4.7 trillion KRW acquiring US-listed triple-leveraged semiconductor ETF (SOXL), accounting for nearly 74% of total purchases of US stocks during the same period. This marks the first rebound since tightening regulations in July and two consecutive months of net selling.
AI Bubble Index at 74, CoreWeave (CRWV.US) stock price may fall below $50
CoreWeave's stock price has dropped nearly 70% from its peak to $54.25, with the short interest ratio rising to 15%. As the AI bubble index reaches an extreme value of 74 and the company faces $3 billion in debt pressure, its share price is at risk of falling below the critical support level of $50.
Cramer Beat the S&P At His Hedge Fund But Advises Retail to Join The Index
Trump Calls Off Iran Strike But Will Oil Hold Above $100?
Crypto prices
More
